Skip to Main Content

Paper Details

Opportunities and challenges for the development of M<sub>1</sub> muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits.
Br J Pharmacol
4
2024
  • 1 - 3

Datasets